Results 81 to 90 of about 182,504 (107)

[Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zheng FY, Ding MM, Lu AD, Jia YP, Zeng HM, Zhang LP.   +5 more
europepmc   +1 more source

[Pathogenic mechanisms of Leber hereditary optic neuropathy caused by m.3472T>C mutation]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Zhang H, Shan W, Yasheng M, Guan M.
europepmc   +1 more source

[Clinicopathological, Genomic Characteristics and Prognostic Analysis in 18 Cases 
of SMARCA4-deficient or SMARCA4-mutated Pulmonary Tumors]. [PDF]

Zhongguo Fei Ai Za Zhi
Liu C, Yang J, Meng F, Zhang L, Wang X, Yu T, Zhong D.   +6 more
europepmc   +1 more source

[Trastuzumab Deruxtecan for EGFR-mutant Lung Adenocarcinoma
with Acquired High-level HER2 Amplification: A Case Report]. [PDF]

Zhongguo Fei Ai Za Zhi
Ge X, Chen H, Cui S.
europepmc   +1 more source

[<i>PIK3CA</i> Somatic Mutations Are Associated With Lymph Node Metastasis in Endometrial Cancer]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Shen Q, Tian C, Luo X, Yang F, Jiang P, Zheng Y.   +5 more
europepmc   +1 more source

[Compound heterozygous plasminogen mutations causing hereditary plasminogen deficiency: a family study and mechanistic analysis]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Lu YF, Yu DD, Xu QY, Wang FJ, Qin LY, Wang MS, Yang LL.   +6 more
europepmc   +1 more source

[Application of polygenic risk score-based comprehensive breast cancer risk assessment in preimplantation embryo selection for a <i>BRCA1</i> mutation carrier]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Ye Y, Hu X, Yan K, Yu J, Chen Y, Zou Y, Luo Q, Zhang D, Zhu Y, Huang H.   +9 more
europepmc   +1 more source

[Research Progress in Imaging Investigation of TERT Promoter Mutations in Gliomas]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Zhong Y, Ma X, Duan Q, Lu H, Lyu J, Lou X.   +5 more
europepmc   +1 more source

[Advances in Targeted Therapy for Advanced Non-small Cell Lung Cancer 
with HER2 Mutation]. [PDF]

Zhongguo Fei Ai Za Zhi
Yu J, Cao B.
europepmc   +1 more source

[Clinical and molecular characteristics of myeloproliferative neoplasms patients with NFE2 gene mutations]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhao SY, Li B, Xu ZF, Qin TJ, Qu SQ, Pan LJ, Jiao M, Gao QY, Wang HJ, Sun Q, Jia YJ, Yan YR, Gong JY, Li FH, Wang X, Xiao ZJ.   +15 more
europepmc   +1 more source